Argent BioPharma Ltd (RGT) NPV (DI)
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
No news items about Argent BioPharma Ltd NPV (DI) were found.
Company announcements Announcements
-
September 2024 Quarterly Report
31 October 2024 07:00
Argent Biopharma Limited NPV (DI)
-
Dispatch of Annual General Meeting Documents
25 October 2024 07:13
Argent Biopharma Limited NPV (DI)
-
Placing to Raise A$200,000
24 October 2024 07:24
Argent Biopharma Limited NPV (DI)
-
Holding(s) in Company
15 October 2024 08:56
Argent Biopharma Limited NPV (DI)
-
Director/PDMR Shareholding
15 October 2024 08:54
Argent Biopharma Limited NPV (DI)
-
Refinancing of Convertible Security Agreement
9 October 2024 07:00
Argent Biopharma Limited NPV (DI)
-
Result of Meeting
1 October 2024 10:33
Argent Biopharma Limited NPV (DI)
-
Annual Report for the year ended 30 June 2024
30 September 2024 09:34
Argent Biopharma Limited NPV (DI)
-
Date of AGM & Closing Date of Director Nominations
25 September 2024 07:50
Argent Biopharma Limited NPV (DI)
-
ASX Delisting Update
23 September 2024 07:24
Argent Biopharma Limited NPV (DI)
-
Director/PDMR Shareholding
12 September 2024 07:00
Argent Biopharma Limited NPV (DI)
-
Company Presentation
6 September 2024 07:00
Argent Biopharma Limited NPV (DI)
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.